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to characterise wild type and mutant proteins by polarographic and
voltametric techniques to investigate the importance of these
residues in ubiquinone-binding. Q242N, S256T and R262K substitu-
tion results in complete loss of AOX electron transfer activity that is
not due to instability of the protein suggesting that these residues,
also identiﬁed as being important in complex II, are critical for Q-
binding in AOX. Of equal interest was the ﬁnding that N247Q
substitution had little effect upon electron transfer or inhibitor
sensitivity. We are currently investigating the importance of this
residue since we believe it is responsible for a difference in
sensitivity to ascofuranone, a very speciﬁc inhibitor of the
alternative oxidase, in Trypanosoma brucei and Trypanosoma vivax.
Results will also be presented as to the importance of Y253 and
H262 in Q-binding.Supported by the BBSRC.
doi:10.1016/j.bbabio.2008.05.294
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The aim of this project is to elucidate the structure of the
alternative oxidase under optimal crystallographic conditions. The
alternative oxidase (AOX), an inner-mitochondrial membrane ubi-
quinol:oxygen oxidoreductase, is responsible for cyanide-resistant
respiration in plants, several fungi and a variety of alpha-
proteobacteria. Importantly, several human parasites, including
Trypanosoma brucei brucei and Blastocystis hominis, also functionally
express the alternative oxidase gene. In the case of trypanosomes,
the causative agent of African sleeping sickness, AOX has been found
to be the sole oxidase present in the bloodstream form of the
kinetoplast parasite. While the alternative oxidase has been
modeled in silico, the exact structure remains unknown. Detailed
knowledge of the structure is essential to the future study of the
enzyme, speciﬁcally in relation to rational drug design of effective
anti-parasitic drugs. Sauromatum guttatum AOX has been over-
expressed in both C41 and heme-deﬁcient Escherichia coli strains,
solubilised in the presence of a variety of detergents, and
subsequently puriﬁed using cobalt afﬁnity gel. Results will be
presented to show the production of an active protein at all stages
of the puriﬁcation process, in addition to demonstrating for the ﬁrst
time that the plant AOX is sensitive to the speciﬁc trypanosomal
inhibitor ascofuranone. This work is supported by a grant from the
BBSRC.
doi:10.1016/j.bbabio.2008.05.295
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The diabetic kidney has an altered energy metabolism which
is partly due to the increased tubular electrolyte load, but also
due to activation of several seemingly different pathways. We
have previously shown that increased oxidative stress and
activation of the polyol pathway result in reduced tissue oxygen
tension throughout the diabetic kidney. Interestingly, we found
that the reduced oxygen availability always was linked to
increased oxygen utilization, even during situations of glomeru-
lar hypoﬁltration, i.e. when the tubular load of electrolytes was
reduced.
We could show that the increased oxygen utilization in the
diabetic kidney in vivo is dependent on reduced nitric oxide
bioavailability, and thus reduced inhibition of mitochondria respira-
tion, but exogenous stimulation of the nitric oxide production was
not sufﬁcient to alone normalize the oxygen tension. When
investigating the cellular oxygen metabolism in the diabetic kidney
at the molecular level, we found that the diabetic kidney has
increased uncoupling protein (UCP)-2 expression. Oxygen consump-
tion by diabetic mitochondria can be stimulated by glutamate alone,
which is in vast contrast to mitochondria from normoglycemic
controls. The glutamate-stimulated oxygen consumption by the
diabetic mitochondria is prevented by either addition of GDP or
removal of the free fatty acids, which further supports the
conclusion of mitochondrial uncoupling. Although remaining to be
supported by future experiments, we propose that the increased
UCP-2 expression in the diabetic kidney is an antioxidant defense,
which serves to reduce the mitochondria superoxide radical
production and thereby preserve the function of the electron
transport chain.
doi:10.1016/j.bbabio.2008.05.296
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We used different human cells to elucidate the molecular
mechanism responsible for biochemical and clinical phenotypes
associated with mutations at nt8993 in the mitochondrial DNA
(mtDNA). The most common human mutations at this nucleotide,
TNG and TNC, change Leu-156 for Arg and Pro, respectively, in
the ATPase6 subunit (homologous to subunit a of E. coli) of the
F1F0-ATPase (ATP synthase). When Pro substitutes for Leu, both
clinical and biochemical phenotypes are rather mild, and ATP
synthesis rate is found less than 20% reduced, matching the
decrease of proton translocation rate through F0 during ATP
synthesis. At variance, the mtDNA 8993TNG mutation, bringing
in the ATPase6 subunit Arg-156 and being associated with severe
syndromes of infancy and childhood, induces a dramatic decrease
of ATP synthesis rate, an impaired proton translocation rate, but
an almost normal ATP hydrolysis rate. Taking into account the
above observations, and on the basis of structural prediction
analysis of mutant ATPase6 subunit, we suggest that the proton
translocation pathway through F0 is impaired by the TNG
mutation, possibly due to partial loss of the Leu-156-containing
transmembrane helix, which is essential for energy transduction
by the ATP synthase. In conclusion, our study demonstrates the
important role of Leu-156 for the ATPase6 structure allowing
mitochondrial F1F0-ATPase energy transduction, and it provides a
molecular mechanism for the pathogenesis of severe human
syndromes. Moreover, our results suggest that mitochondrial
S75ABSTRACTS / Biochimica et Biophysica Acta 1777 (2008) S2–S111
